Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Vogel

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|November 23, 1987
Antibody conjugates with cobra venom factor. Synthesis and biochemical characterizationE C Petrella, S D Wilkie, C A Smith, et al.
Molecular Immunology|April 1, 1983
The membrane attack complex of complement and its precursor proteins lack phospholipase activityC W Vogel, A Plückthun, E R Podack, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Structure and function of cobra venom factor, the complement-activating protein in cobra venomC W Vogel, R Bredehorst, D C Fritzinger, et al.
Glycobiology|April 26, 2001
N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structuresD C Gowda, J Glushka, Halbeek Hv, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cellsM W Ollert, K David, C Schmitt, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Mechanisms of in vivo anti-neuroblastoma activity of human natural IgMM W Ollert, K David, C Vollmert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction stepsM W Ollert, J V Kadlec, K David, et al.
Nature Medicine|June 1, 1996
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humansK David, M W Ollert, H Juhl, et al.
Klinische Padiatrie|September 3, 1999
[Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]C Schmitt, K David, J Hiller, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 27, 2001
Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysisS Sharma, T Jabeen, R K Singh, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|November 23, 1987
Antibody conjugates with cobra venom factor. Synthesis and biochemical characterizationE C Petrella, S D Wilkie, C A Smith, et al.
Molecular Immunology|April 1, 1983
The membrane attack complex of complement and its precursor proteins lack phospholipase activityC W Vogel, A Plückthun, E R Podack, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Structure and function of cobra venom factor, the complement-activating protein in cobra venomC W Vogel, R Bredehorst, D C Fritzinger, et al.
Glycobiology|April 26, 2001
N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structuresD C Gowda, J Glushka, Halbeek Hv, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cellsM W Ollert, K David, C Schmitt, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Mechanisms of in vivo anti-neuroblastoma activity of human natural IgMM W Ollert, K David, C Vollmert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction stepsM W Ollert, J V Kadlec, K David, et al.
Nature Medicine|June 1, 1996
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humansK David, M W Ollert, H Juhl, et al.
Klinische Padiatrie|September 3, 1999
[Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]C Schmitt, K David, J Hiller, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 27, 2001
Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysisS Sharma, T Jabeen, R K Singh, et al.
Pageof 7